In this episode, we discuss ivermectin as a potential therapeutic for COVID-19 and review available randomized trials evaluating this drug.
- Chaccour et al) E-Clinical Medicine
- Lopez-Medina et al.) JAMA
- Schwartz et al (not yet published))
- IDSA guidelines)
- NIH Treatment guidelines)
Show notes: FOAMcast.org)
Thanks for listening! Jeremy Faust and Lauren Westafer
